Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
50.3 SEK | -69.20% | -5.78% | -38.73% |
05-31 | Hansa Biopharma Finalizes Patient Randomization for Use of Imlifidase inKidney Transplantation Trial | MT |
05-31 | Hansa Biopharma Completes Randomization in Pivotal Phase 3 Us Confides Trial | CI |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
55.7B | - | |||||
39.91B | ||||||
39.57B | ||||||
28.16B | ||||||
26.3B |